WESTON, Fla., May 14, 2024 /PRNewswire/ - Apotex Corp. announced today the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
Enforcement Report - Week of June 7, 2023
Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic version of Cetrorelix Acetate...
Akorn's Generic Cetrorelix Acetate Receives Approval in the U.S.
EMA warns of shortage of IVF drugCetrotide due to Merck KGaA manufacturing issue
The European Medicines Agency recently noted the shortage of a drug that is used frequently in IVF procedures where women have ovarian stimulation (i.e. fertility treatment where the ovaries are stimulated to produce more eggs).
Enforcement Report - Week of July 15
Health Canada Issues Recall of EMD Serono (A Division of EMD Inc., Canada)` Cetrotide